Nissan Motor(US:NSANY) Di Yi Cai Jing·2025-11-06 11:55Core Viewpoint - Nissan is actively pursuing its Re:Nissan plan, which includes selling its headquarters building in Yokohama to Minth Group for 97 billion yen (approximately 4.5 billion RMB) to improve its financial situation [2] Financial Performance - For the second quarter of fiscal year 2025, Nissan reported a sales revenue of 2.87 trillion yen, slightly above the forecast of 2.86 trillion yen, but incurred a net loss of 1.0616 trillion yen, better than the expected loss of 1.1398 trillion yen [2] - Global sales volume decreased from 809,000 units to 773,000 units, representing a year-on-year decline of 4.5% [2] - Sales in China fell to 158,000 units, down 8.1% year-on-year; Japan's sales dropped to 98,000 units, down 20.8%; North America saw an increase from 299,000 to 319,000 units, up 6.7%; Europe sales decreased to 72,000 units, down 10.6%; other regions also experienced a 6.3% decline [2] Sales Forecast - Nissan forecasts total vehicle sales for the fiscal year 2025 to remain at 3.25 million units, with specific regional expectations: China at 645,000 units (down 7.4%), Japan at 445,000 units (down 3.4%), North America at 1.3 million units (down 0.2%), and Europe at 340,000 units (down 3.1%) [3] - The North American market shows positive momentum, being the only region with sales growth in the second quarter, while the Chinese market benefits from the N7 model [3] Cost Reduction Measures - Nissan aims to achieve a cost reduction of approximately 500 billion yen, with 250 billion yen from variable costs and another 250 billion yen from fixed costs, targeting a return to positive operating profit and free cash flow by fiscal year 2026 [3] - Specific measures include reducing the number of production plants globally from 17 to 10 by fiscal year 2027, lowering production capacity to 2.5 million units, with a potential increase of 500,000 units if necessary [4] - The company plans to cut 20,000 jobs, with 65% from manufacturing, 18% from sales and general management, and 17% from R&D, primarily affecting contract workers [4]